CMS’ new reimbursement rate for FDG PET of $1375.00 has both good and disappointing news for those interested in bringing Positron Emission Tomography (PET) to the broadest number of patients, ...
BEDFORD, Mass., December 12, 2024--(BUSINESS WIRE)--Delix Therapeutics, a clinical-stage neuroscience company developing novel neuroplasticity-promoting therapeutics for psychiatric and neurological ...
Results suggest that this scalable model of Hospital at Home is safe, feasible, highly satisfactory, and may be associated with substantial reductions in hospital readmissions. 259 Prospect Plains Rd, ...
Multiple well-tolerated doses with pharmacodynamic activity were identified and will be included in a planned Phase 2b study in major depressive disorder BOSTON, December 11, 2024--(BUSINESS ...
The American College of Neuropsychopharmacology (ACNP) has named Andrew Holmes, Ph.D. as one of two winners of the 2016 Daniel H. Efron Research Award. Dr. Holmes directs the Laboratory of Behavioral ...
MindMed Scientific Presentations at American College of Neuropsychopharmacology (ACNP) 2024 Congress
NEW YORK--(BUSINESS WIRE)--Mind Medicine (MindMed) Inc. (NASDAQ: MNMD), (the "Company" or "MindMed"), a clinical-stage biopharmaceutical company developing novel product candidates to treat brain ...
BEDFORD, Mass.--(BUSINESS WIRE)--Delix Therapeutics, a clinical-stage neuroscience company developing novel neuroplasticity-promoting therapeutics for psychiatric and neurological disorders, today ...
Laura J. Zitella, MS, RN, ACNP-BC, AOCN, explains that later cytopenias should be monitored in patients undergoing CAR T-cell ...
Meet Danielle McCamey DNP, CRNP, ACNP-BC, FCCP, the founder of DNPs of Color, a nursing organization with a mission to increase diversity, equity, and inclusion in doctoral studies, clinical practice, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback